Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global regenerative medicine market size reached US$ 18.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.4 Billion by 2028, exhibiting a growth rate (CAGR) of 22.4% during 2023-2028.

Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer’s, Parkinson’s and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.

The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Stem Cell Therapy
Biomaterial
Tissue Engineering
Others

Breakup by Application:

Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others

Breakup by End User:

Hospitals
Specialty Clinics
Others

Breakup by Region:

North America

United States
Canada


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global regenerative medicine market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global regenerative medicine market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology 
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Regenerative Medicine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Stem Cell Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biomaterial
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Tissue Engineering
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Bone Graft Substitutes
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Osteoarticular Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Central Nervous System
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Specialty Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
 9.1.1.1 Market Trends
 9.1.1.2 Market Forecast
9.1.2 Canada
 9.1.2.1 Market Trends
 9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
 9.2.1.1 Market Trends
 9.2.1.2 Market Forecast
9.2.2 Japan
 9.2.2.1 Market Trends
 9.2.2.2 Market Forecast
9.2.3 India
 9.2.3.1 Market Trends
 9.2.3.2 Market Forecast
9.2.4 South Korea
 9.2.4.1 Market Trends
 9.2.4.2 Market Forecast
9.2.5 Australia
 9.2.5.1 Market Trends
 9.2.5.2 Market Forecast
9.2.6 Indonesia
 9.2.6.1 Market Trends
 9.2.6.2 Market Forecast
9.2.7 Others
 9.2.7.1 Market Trends
 9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
 9.3.1.1 Market Trends
 9.3.1.2 Market Forecast
9.3.2 France
 9.3.2.1 Market Trends
 9.3.2.2 Market Forecast
9.3.3 United Kingdom
 9.3.3.1 Market Trends
 9.3.3.2 Market Forecast
9.3.4 Italy
 9.3.4.1 Market Trends
 9.3.4.2 Market Forecast
9.3.5 Spain
 9.3.5.1 Market Trends
 9.3.5.2 Market Forecast
9.3.6 Russia
 9.3.6.1 Market Trends
 9.3.6.2 Market Forecast
9.3.7 Others
 9.3.7.1 Market Trends
 9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
 9.4.1.1 Market Trends
 9.4.1.2 Market Forecast
9.4.2 Mexico
 9.4.2.1 Market Trends
 9.4.2.2 Market Forecast
9.4.3 Others
 9.4.3.1 Market Trends
 9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10  SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Allergan PLC (AbbVie Inc.)
 14.3.1.1 Company Overview
 14.3.1.2 Product Portfolio 
 14.3.1.3 Financials 
 14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
 14.3.2.1 Company Overview
 14.3.2.2 Product Portfolio
 14.3.2.3 Financials 
 14.3.2.4 SWOT Analysis
14.3.3 Baxter International Inc.
 14.3.3.1 Company Overview
 14.3.3.2 Product Portfolio 
 14.3.3.3 Financials 
 14.3.3.4 SWOT Analysis
14.3.4 BD (Becton, Dickinson and Company)
 14.3.4.1 Company Overview
 14.3.4.2 Product Portfolio 
 14.3.4.3 Financials 
 14.3.4.4 SWOT Analysis
14.3.5 Integra Lifesciences Holdings Corporation
 14.3.5.1 Company Overview
 14.3.5.2 Product Portfolio 
 14.3.5.3 Financials 
 14.3.5.4 SWOT Analysis
14.3.6 Medtronic Plc
 14.3.6.1 Company Overview
 14.3.6.2 Product Portfolio 
 14.3.6.3 Financials
 14.3.6.4 SWOT Analysis
14.3.7 Mimedx Group Inc.
 14.3.7.1 Company Overview
 14.3.7.2 Product Portfolio
 14.3.7.3 Financials 
14.3.8 Novartis AG
 14.3.8.1 Company Overview
 14.3.8.2 Product Portfolio 
 14.3.8.3 Financials
 14.3.8.4 SWOT Analysis
14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
 14.3.9.1 Company Overview
 14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific Inc.
 14.3.10.1 Company Overview
 14.3.10.2 Product Portfolio 
 14.3.10.3 Financials
 14.3.10.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings